Recently, it was showed that levels of DARPP-32, a key downstream effector in transducing dopamine signaling, is decreased in PFC of schizophrenia subjects [10,11] and that there are DARPP-32 genetic variations associated with PFC cognitive functions [30]. The gene discussed is PPP1R1B; the disease is schizophrenia.